These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25622902)

  • 21. Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.
    Richards JS; Fan HY; Liu Z; Tsoi M; Laguë MN; Boyer A; Boerboom D
    Oncogene; 2012 Mar; 31(12):1504-20. PubMed ID: 21860425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicular expression of c-Kit/SCF and inhibin-alpha in mouse ovary during development.
    Kang JS; Lee CJ; Lee JM; Rha JY; Song KW; Park MH
    J Histochem Cytochem; 2003 Nov; 51(11):1447-58. PubMed ID: 14566017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv).
    Arguello F; Furlanetto RW; Baggs RB; Graves BT; Harwell SE; Cohen HJ; Frantz CN
    Cancer Res; 1992 Apr; 52(8):2304-9. PubMed ID: 1559233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
    Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR
    Cancer Cell; 2007 Apr; 11(4):321-33. PubMed ID: 17418409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.
    Chan WY; Cheung KK; Schorge JO; Huang LW; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Am J Pathol; 2000 Feb; 156(2):409-17. PubMed ID: 10666369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases.
    Mullany LK; Liu Z; Wong KK; Deneke V; Ren YA; Herron A; Richards JS
    Mol Endocrinol; 2014 Jan; 28(1):127-37. PubMed ID: 24264574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.
    Ren YA; Mullany LK; Liu Z; Herron AJ; Wong KK; Richards JS
    Cancer Res; 2016 Apr; 76(8):2206-18. PubMed ID: 26964623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors.
    Upton DH; Fuller ES; Colvin EK; Walters KA; Jimenez M; Desai R; Handelsman DJ; Howell VM; Allan CM
    Horm Cancer; 2015 Aug; 6(4):142-52. PubMed ID: 25943777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.
    Rajanahally S; Agno JE; Nalam RL; Weinstein MB; Loveland KL; Matzuk MM; Li Q
    Reprod Biol Endocrinol; 2010 Jun; 8():69. PubMed ID: 20565978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of mutations affecting gonadotropin production or responsiveness on expression of inhibin subunit mRNA and protein in the mouse ovary.
    Hirst RC; Abel MH; Wilkins V; Simpson C; Knight PG; Zhang FP; Huhtaniemi I; Kumar TR; Charlton HM
    Reproduction; 2004 Jul; 128(1):43-52. PubMed ID: 15232063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary.
    Tate G; Tajiri T; Suzuki T; Mitsuya T
    Cancer Genet Cytogenet; 2009 Apr; 190(1):15-20. PubMed ID: 19264228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter.
    Hsu SY; Kubo M; Chun SY; Haluska FG; Housman DE; Hsueh AJ
    Mol Endocrinol; 1995 Oct; 9(10):1356-66. PubMed ID: 8544844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.
    Guan B; Rahmanto YS; Wu RC; Wang Y; Wang Z; Wang TL; Shih IeM
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24899687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
    Roberts VJ; Barth S; el-Roeiy A; Yen SS
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of death receptor Fas in germ cell degeneration in gonads of Kit-deficient Wv/Wv mutant mice.
    Sakata S; Sakamaki K; Watanabe K; Nakamura N; Toyokuni S; Nishimune Y; Mori C; Yonehara S
    Cell Death Differ; 2003 Jun; 10(6):676-86. PubMed ID: 12761576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.
    Yong C; Moose DL; Bannick N; Gutierrez WR; Vanneste M; Svensson R; Breheny P; Brown JA; Dodd RD; Cohen MB; Henry MD
    PLoS One; 2020; 15(9):e0232807. PubMed ID: 32986721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexually dimorphic roles of steroid hormone receptor signaling in gonadal tumorigenesis.
    Burns KH; Agno JE; Chen L; Haupt B; Ogbonna SC; Korach KS; Matzuk MM
    Mol Endocrinol; 2003 Oct; 17(10):2039-52. PubMed ID: 12855748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.